HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,618,163 | -40.7% | 201,958 | -36.3% | 0.00% | -50.0% |
| Q2 2023 | $11,155,336 | +4.1% | 317,003 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $10,720,105 | +78.5% | 328,334 | +201.2% | 0.00% | +100.0% |
| Q4 2022 | $6,007,222 | -18.1% | 109,024 | -34.2% | 0.00% | -50.0% |
| Q3 2022 | $7,335,000 | +120.3% | 165,611 | +142.6% | 0.00% | +100.0% |
| Q2 2022 | $3,330,000 | +7.5% | 68,277 | +7.3% | 0.00% | 0.0% |
| Q1 2022 | $3,097,000 | +54.8% | 63,659 | +35.7% | 0.00% | – |
| Q4 2021 | $2,000,000 | -4.3% | 46,906 | -14.0% | 0.00% | – |
| Q3 2021 | $2,090,000 | +159.3% | 54,516 | +90.9% | 0.00% | – |
| Q2 2021 | $806,000 | +76.4% | 28,561 | +106.7% | 0.00% | – |
| Q1 2021 | $457,000 | +42.4% | 13,820 | +55.5% | 0.00% | – |
| Q4 2020 | $321,000 | -75.1% | 8,885 | -76.7% | 0.00% | – |
| Q3 2020 | $1,290,000 | – | 38,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |